Lisata Therapeutics, Inc. (LSTA): Shareholders' Equity
$14.86M
As of 2025-12-31
$8.24M
As of 2026-06-30
-39.3%
3-year compound annual growth
-14.5%
5-year compound annual growth
-4.6%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.86M | -49.8% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $29.57M | -38.6% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $48.15M | -27.7% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $66.58M | -27.8% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $92.25M | +183.9% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $32.50M | +56.1% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $20.82M | -44.8% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $37.73M | -25.3% | 2020-03-05, Balance as of period end |
| 2017-12-31 | $50.51M | +934.2% | 2019-03-14, Balance as of period end |
| 2016-12-31 | $4.88M | -79.4% | 2018-03-22, Balance as of period end |
| 2015-12-31 | $23.71M | -59.5% | 2017-03-17, Balance as of period end |
| 2014-12-31 | $58.51M | -6.4% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $62.54M | +88.5% | 2015-03-02, Balance as of period end |
| 2012-12-31 | $33.18M | -46.5% | 2014-03-13, Balance as of period end |
| 2011-12-31 | $62.03M | +27.5% | 2013-03-11, Balance as of period end |
| 2010-12-31 | $48.66M | n/a | 2012-03-20, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $14.86M | -49.8% |
| Clene Inc. (CLNN) | 2025-12-31 | -$17.59M | n/m |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$37.0K | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$6.28M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.14M | -57.0% |
| iBio, Inc. (IBIO) | 2026-06-30 | $85.71M | +476.0% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $11.11M | +806.2% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $3.76M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $9.83M | -16.8% |
Compare LSTA, CLNN, SER, RGBP side by side · Screen every company in Pharmaceutical Preparations ↗